Literature DB >> 11922912

Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing.

Sébastien Bonnet1, Eric Dubuis, Christophe Vandier, Stéphanie Martin, Roger Marthan, Jean-Pierre Savineau.   

Abstract

OBJECTIVE: Chronic hypoxia (CH) induces selective pulmonary hypertension which is accompanied by structural and functional alterations in the pulmonary vasculature. Little information is available on the regression of CH-induced functional alterations of pulmonary wall. In the present work, we investigated the reversal of CH-induced pulmonary hypertension with a special focus on alterations in the electrophysiological properties of pulmonary artery smooth muscle cells (PAMCs) after normoxia recovery.
METHODS: Rats were exposed to a hypobaric environment for 3 weeks (CH rats) and then subjected to a normoxic environment for 3 weeks (normoxia-recovery group) and compared with rats maintained in a normoxic environment (control rats). Electrophysiological properties of PAMCs were studied using conventional microelectrodes and patch-clamp technique.
RESULTS: CH rats exhibited a threefold increase in pulmonary blood pressure compared to control rats and this increase was fully reversed following 3 weeks of normoxia. PAMCs from CH rats were depolarised (about 20 mV), had an elevated calcium concentration and exhibited a hypersensitivity to 4-aminopyridine (4-AP) of membrane potential as well as the tone of arterial rings compared with tissues from control rats. Whole cell patch-clamp recordings indicated that voltage gated potassium channel currents I(Kv) and I(K(N)) were decreased in PAMCs from CH rats with a hyper sensitivity of I(K(N)) to 4-AP. CH-induced alterations in electrophysiological properties of PAMCs were also fully reversed after 3 weeks of normoxia recovery.
CONCLUSIONS: Both the increase in the pulmonary blood pressure and alterations in electrophysiological properties of PASMCs simultaneously reverse after normoxia recovery. This complete reversibility of all of the CH-induced pulmonary vascular alterations suggests that curative treatments for PAHT may now be designed aimed at targeting the very limited key factors implicated in hypoxia sensing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922912     DOI: 10.1016/s0008-6363(01)00548-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.

Authors:  Jun Wan; Aya Yamamura; Adriana M Zimnicka; Guillaume Voiriot; Kimberly A Smith; Haiyang Tang; Ramon J Ayon; Moumita S R Choudhury; Eun A Ko; Jun Wang; Chen Wang; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-17       Impact factor: 5.464

2.  Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension.

Authors:  Sébastien Bonnet; Eric Dumas-de-La-Roque; Hugues Bégueret; Roger Marthan; Michael Fayon; Pierre Dos Santos; Jean-Pierre Savineau; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

Review 3.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

4.  Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension.

Authors:  Marie Billaud; Diana Dahan; Roger Marthan; Jean-Pierre Savineau; Christelle Guibert
Journal:  Respir Res       Date:  2011-03-17

5.  Requirement of Pretone by Thromboxane A(2) for Hypoxic Pulmonary Vasoconstriction in Precision-cut Lung Slices of Rat.

Authors:  Su Jung Park; Hae Young Yoo; Hye Jin Kim; Jin Kyoung Kim; Yin-Hua Zhang; Sung Joon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-02-28       Impact factor: 2.016

6.  Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery.

Authors:  Nazinigouba Ouédraogo; Boutchi Mounkaïla; Huguette Crevel; Roger Marthan; Etienne Roux
Journal:  BMC Anesthesiol       Date:  2006-03-03       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.